McKesson (NYSE:MCK) was upgraded by Jefferies Group from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, Marketbeat reports. The brokerage currently has a $205.00 target price on the stock. Jefferies Group’s target price would suggest a potential upside of 16.00% from the company’s previous close. Jefferies Group also issued estimates for McKesson’s Q3 2018 earnings at $2.91 EPS, Q4 2018 earnings at $3.58 EPS, FY2018 earnings at $12.23 EPS and FY2019 earnings at $14.12 EPS.
Other analysts have also issued research reports about the stock. Mizuho set a $168.00 price target on shares of McKesson and gave the stock a “hold” rating in a research note on Tuesday, October 24th. Robert W. Baird restated a “buy” rating and issued a $200.00 price target on shares of McKesson in a research note on Wednesday, January 17th. Needham & Company LLC set a $179.00 price target on shares of McKesson and gave the stock a “buy” rating in a research note on Monday, October 16th. Cowen upgraded shares of McKesson from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $176.00 to $189.00 in a research note on Tuesday, October 10th. Finally, Royal Bank of Canada reiterated a “hold” rating and set a $170.00 target price on shares of McKesson in a research note on Friday, October 27th. Two analysts have rated the stock with a sell rating, six have given a hold rating and eleven have assigned a buy rating to the stock. McKesson presently has a consensus rating of “Hold” and a consensus target price of $178.68.
Shares of McKesson (NYSE:MCK) traded up $1.52 during trading hours on Wednesday, hitting $176.72. 1,334,537 shares of the company were exchanged, compared to its average volume of 1,590,000. The company has a current ratio of 1.05, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $36,840.00, a price-to-earnings ratio of 8.37, a PEG ratio of 1.65 and a beta of 1.23. McKesson has a fifty-two week low of $133.82 and a fifty-two week high of $178.00.
In other McKesson news, Chairman John H. Hammergren sold 65,000 shares of the business’s stock in a transaction on Thursday, December 14th. The shares were sold at an average price of $160.00, for a total transaction of $10,400,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.20% of the stock is owned by insiders.
Institutional investors and hedge funds have recently made changes to their positions in the company. IHT Wealth Management LLC boosted its holdings in shares of McKesson by 64.2% during the second quarter. IHT Wealth Management LLC now owns 486 shares of the company’s stock valued at $1,027,000 after acquiring an additional 190 shares during the period. WFG Advisors LP boosted its holdings in shares of McKesson by 5.0% during the second quarter. WFG Advisors LP now owns 859 shares of the company’s stock valued at $141,000 after acquiring an additional 41 shares during the period. CWH Capital Management Inc. acquired a new position in shares of McKesson during the second quarter valued at $165,000. Wealthcare Advisory Partners LLC acquired a new position in shares of McKesson during the third quarter valued at $155,000. Finally, YorkBridge Wealth Partners LLC boosted its holdings in shares of McKesson by 9.9% during the second quarter. YorkBridge Wealth Partners LLC now owns 1,291 shares of the company’s stock valued at $212,000 after acquiring an additional 116 shares during the period. 87.84% of the stock is owned by institutional investors.
ILLEGAL ACTIVITY NOTICE: This story was originally posted by American Banking and Market News and is the sole property of of American Banking and Market News. If you are accessing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The correct version of this story can be read at https://www.americanbankingnews.com/2018/01/28/mckesson-mck-lifted-to-buy-at-jefferies-group.html.
McKesson Company Profile
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
